STOCK TITAN

Eloxx Pharmaceut (ELOX) Net Income by Year

ELOX

Eloxx Pharmaceut reported a net loss of $6.0M in fiscal year 2025. This represents a decrease of 90.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Eloxx Pharmaceut has filed alongside them.

FY2025 annual
Net Income -$6.0M
YoY -90.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ELOX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-1/AFY24S-1/AFY23S-1/AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$6.0M-90.7%-$3.1MN/A-$36.1M+46.0%-$66.7M-93.0%-$34.6M+32.0%-$50.9M-7.8%-$47.2M-122.4%-$21.2M-115.4%-$9.8M-53.7%-$6.4M+30.6%-$9.2M-50.7%-$6.1M-20.9%-$5.1M+30.3%-$7.3M

ELOX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ2'2510-QQ1'2510-QQ4'24S-1/AQ4'23S-1/AQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-QQ3'2210-Q
Net Income-$4.5M-138.1%-$3.8M-119.7%N/A-$1.9M-$1.7MN/AN/A-$3.6M+52.2%-$4.3M+59.1%-$6.2M+46.4%N/A-$7.5M+24.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Eloxx Pharmaceut financials

Frequently Asked Questions

What was Eloxx Pharmaceut's net income in fiscal year 2025?

Eloxx Pharmaceut reported a net loss of $6.0M in fiscal year 2025.

How fast is Eloxx Pharmaceut's net income growing?

Eloxx Pharmaceut (ELOX) net income fell by 90.7% year over year, from -$3.1M to -$6.0M in fiscal year 2025.

How has Eloxx Pharmaceut's net income changed over the years?

Across the 15 fiscal years this page covers, Eloxx Pharmaceut (ELOX) net income went from -$7.3M in fiscal year 2011 to -$6.0M in fiscal year 2025.

Eloxx Pharmaceut (ELOX) reported -$4.5M in net income in Q2 2026. This represents a decrease of 138.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Eloxx Pharmaceut (ELOX) reported on that line in every period on record.